Fundamental Data for RMD

RESMED INC(NYSE:RMD)

ResMed Inc. is a leading designer, manufacturer and distributor of medical equipment for treating and diagnosing sleep disordered breathing. Sleep disordered breathing includes sleep apnea and related respiratory conditions. The company sells a comprehensive range of diagnostic and treatment devices in countries through a combination of wholly owned subsidiaries and independent distributors.

# Employees: 2900

Address: 14040 Danielson Street,Poway,CA,USA

Phone: 858 746-2400

Fax: 858 622-2043

Website: www.resmed.com

Email: reception@resmed.com

Sector: Medical

Industry: MED PRODUCTS

Executive Officers

Peter C. Farrell (Chmn.)

Kieran T. Gallahue (Presi.; C.E.O.)

Brett A. Sandercock (C.F.O.)

Christopher G. Roberts (Dir.)

Michael A. Quinn (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/4/2010

Mean EPS (Next Qtr): $0.55

Mean EPS (Year): $2.28

Mean Estimate(Long Term): $17.06

P/E Ratio(Based on EPS estimate): 22.060

Number of Estimates: 9

Shares Performance

Period	RMD	Compare to S&P
YTD	34.07 %	10.96 %
4 Weeks	1.17 %	0.08 %
12 Weeks	9.74 %	3.46 %

Shares Information

Analyst Coverage: Y

Avg Volume: 839527

Shares Outstanding: 75M

Market Cap: $3.80B

52 Week High: $51.18

52 Week Low: $31.04

P/E Ratio: 23.260

PEG Ratio: 1.290

Split: On 10/3/2005 RMD split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -7.94 %

EPS Growth in Last Year: 61.11 %

Sales Growth in Last Quarter: -1.97 %

Sales Growth in Last Quarter: 13.33 %

Financials

Qtr Book Value: $3.16

Cash Flow/Share: $18.26

Change in Payout Ratio: -0.010

Price/Sales: 4.000